Key Points
The healthcare solutions specialist is also on track to top analyst estimates for the full year.
The company saw growth in several key client segments.
- 10 stocks we like better than Agilent Technologies ›
Agilent Technologies (NYSE: A) had a Thursday to remember, at least as far as its equity was concerned. The medical device and healthcare tech specialist posted its latest quarterly earnings report just after market close the previous day, and investors reacted very positively to it in Thursday's trading session. Their exuberance lifted the share price by nearly 17%.
Quite a healthy quarter
Agilent booked revenue of $1.83 billion in its fiscal second quarter of 2026, up 10% year over year. Its net income not under generally accepted accounting principles (GAAP) saw a steeper rise, advancing by 14% to $423 million, or $1.49 per share.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
With those figures, Agilent beat the average analyst estimates on both the top and bottom lines. Prognosticators tracking the stock were modeling $1.8 billion in revenue and $1.41 per share in non-GAAP (adjusted) net income.
All three of Agilent's reporting units saw revenue growth during the quarter, hence the double-digit improvements. This was led by the Applied Markets Group with a 14% rise to $344 million. Close behind was the life sciences and diagnostics segment, which saw a 12% boost to $732 million. Finally, Agilent CrossLab's take increased by 6% to $759 million.
Sunny future
With these tailwinds at its back, Agilent management lifted the bottom end of its full-year 2026 revenue guidance; the range now stands at $7.39 billion to $7.49 billion. It made a more dramatic change to its adjusted net income projection, upping it to $6 to $6.10 per share from the previous estimate of $5.90 to $6.04.
It's impressive enough when a company posts substantial revenue gains in one or a few of its revenue streams; Agilent not only achieved this in the quarter but also delivered double-digit improvements in two of its three businesses. That, plus the notable bottom-line guidance raise, would give me plenty of confidence in Agilent's future.
Should you buy stock in Agilent Technologies right now?
Before you buy stock in Agilent Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Agilent Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,072!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,303,352!*
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of May 28, 2026.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
